Sökning: "subarachnoid hemorrhage SAH"
Visar resultat 1 - 5 av 20 avhandlingar innehållade orden subarachnoid hemorrhage SAH.
1. Life after Subarachnoid Hemorrhage
Sammanfattning : Aneurysmal subarachnoid hemorrhage (SAH) is a devastating disease with mean age of 59 years. SAH accounts for 5% of all stroke and more than one quarter of potential life years lost through stroke. With the advanced neurosurgical methods of today two thirds of the patients survive. LÄS MER
2. Subarachnoid Hemorrhage in the Elderly
Sammanfattning : Subarachnoid hemorrhage (SAH) is a disease with high risk of mortality and morbidity. Elderly patients have an even higher risk of poor outcome. The incidence of SAH increases with age and the elderly constitute a substantial and increasing proportion of the population. Thus, the management of elderly SAH patients is an imminent clinical challenge. LÄS MER
3. Neurointensive care of subarachnoid hemorrhage : Clinical and neurochemical aspects
Sammanfattning : Neurointensive care (NIC) has gained terrain in the treatment of patients with various acute cerebral conditions. It is based on the concept that an unfavorable clinical outcome, to a certain extent, results from all secondary ischemic insults sustained by the brain during the acute phase of the disease. LÄS MER
4. Monitoring of extracellular substances after spontaneous and experimental subarachnoid hemorrhage
Sammanfattning : Even though survival is considerably enhanced after surgical treatment of an aneurysmal subarachnoid hemorrhage (SAH), there is a critical period, which keeps the patient in intensive care for days or even weeks. Complications, such as vasospasm, ischemia and brain edema ultimately lead to further brain damage. LÄS MER
5. Metabolic and Endocrine Response in the Acute Stage of Subarachnoid Hemorrhage
Sammanfattning : The rupture of an aneurysm in subarachnoid hemorrhage (SAH) is a dramatic event causing a severe impact on the brain and a transient or permanent ischemic condition. Several types of responses to meet the challenges of SAH have been found in the acute phase, including activation of the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system, elevated levels of brain natriuretic peptide (BNP), and disturbances in cerebral and systemic metabolism. LÄS MER